A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Osteoarthritis Pain of the Knee

In brief

The purpose of this study is to evaluate the analgesic efficacy, safety, and tolerability of VM902A twice daily compared to placebo in subjects with moderate to severe chronic pain due to OA of the knee.

Key facts

Study ID
NCT02847702
Run by
Purdue Pharma LP
People needed
75
Starts
2016-08-01
Expected to finish
2016-11-22
Last updated by the study team
2017-11-22

Who can join

Age: 40 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.